Status:
UNKNOWN
Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer
Lead Sponsor:
Soroka University Medical Center
Conditions:
Non-Small Cell Lung Cancer
Measles
Eligibility:
All Genders
18-80 years
Phase:
PHASE1
PHASE2
Brief Summary
The objectives of the study are to assess the efficacy and safety of live, attenuated measles vaccine as consolidation therapy in patients with measles-positive, non-small cell lung cancer with locall...
Detailed Description
This is a single-institution, non-randomized phase 1/2 study in patients with locally-advanced or metastatic NSCLC in remission after receiving standard systemic chemotherapy of four cycles of combina...
Eligibility Criteria
Inclusion
- Patients in remission after first-line chemotherapy
Exclusion
- Progressive disease
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00828022
Start Date
March 1 2009
Last Update
January 23 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Oncology, Soroka Medical Center
Beersheba, Israel, 84101